COMMUNIQUÉS West-GlobeNewswire

Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement

07/03/2018 - 16:03

Regulated Information - Inside Information - 7 March 2018 - 4 pm CET NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, [...]

Bone Therapeutics collecte 19,45 M€ d'engagements dans le cadre d'un placement d'obligations convertibles

07/03/2018 - 16:03

Information réglementée - Information confidentielle - 7 mars 2018 - 16h00 CET LE PRÉSENT COMMUNIQUÉ NE DOIT PAS ÊTRE PUBLIÉ, DISTRIBUÉ OU DIFFUSÉ, TOTALEMENT OU PARTIELLEMENT, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS- [...]

Statement by Irina Maligina, Guardian of Inheritance of Valerijs Maligins

07/03/2018 - 15:14

March 7, 2018 Statement by Irina Maligina, Guardian of Inheritance of Valerijs Maligins AS Olainfarm has received the following statement of Irina Maligina, guardian of inheritance of Valerijs Maligins: Protection of [...]

Trinity Biotech announces Quarter 4 and Fiscal Year 2017 Financial Results

07/03/2018 - 15:11

DUBLIN, Ireland , March 07, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB ), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today [...]

Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio

07/03/2018 - 15:02

Company announcement - No. 8 / 2018 Zealand Pharma 2017 full-year results in line with guidance - considerable progress in the clinical portfolio Copenhagen, March 7, 2018 - Zealand Pharma A/S ("Zealand") (CVR No. 20 04 [...]

Flexion Therapeutics to Present at the Cowen 38th Annual Health Care Conference

07/03/2018 - 15:00

BURLINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) will be presenting at the Cowen 38th Annual Health Care Conference in Boston, Massachusetts. Michael Clayman, M.D., [...]

Paradise Detox, a Medically Assisted Detox and Inpatient Rehab Center, Opens Near San Diego

07/03/2018 - 15:00

LA MESA, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Substance abuse are among the most pressing public health and safety issues facing the United States today. As the leading cause of death among people under the age of [...]

SELLAS Life Sciences Announces $10,700,000 Private Placement

07/03/2018 - 15:00

- Financing Will Support Advancement of its Late-Stage Immuno-Oncology Pipeline - - Lead Candidate, Galinpepimut-S (GPS), On-Target for Initiation of Phase 3 Acute Myeloid Leukemia (AML) Study and Phase 1/2 Basket Trial [...]

Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference

07/03/2018 - 14:30

HAYWARD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical company focused on developing and commercializing products to treat serious and life-threatening [...]

Assure Holdings Adds New Surgeon Partner in Texas and Performs First Case

07/03/2018 - 14:30

PARKER, Colo., March 07, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring services, has added Dr. Jeffrey Ratusznik to its [...]

B.C. pharmacists on the frontline to help in opioid crisis

07/03/2018 - 14:05

VANCOUVER, British Columbia, March 07, 2018 (GLOBE NEWSWIRE) -- While 2017 is marked as the worst year yet in B.C.’s overdose crisis, B.C.’s community pharmacists continue to step in to help patients tackle critical [...]

Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in March

07/03/2018 - 14:01

SAN CARLOS, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]

CASMED to Report Fourth-Quarter and 2017 Full-Year Financial Results and Hold Conference Call on March 14

07/03/2018 - 14:00

BRANFORD, Conn., March 07, 2018 (GLOBE NEWSWIRE) -- CAS Medical Systems, Inc. (NASDAQ: CASM ) (CASMED), a leader in medical devices for non-invasive patient monitoring, announces that it will report financial results [...]

T2 Biosystems Reports Granting of Inducement Award

07/03/2018 - 14:00

LEXINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO ) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Allena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference

07/03/2018 - 14:00

NEWTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA ), a late-stage, clinical biopharmaceutical company dedicated to developing and commercializing first-in-class, oral enzyme [...]

aTyr Pharma to Host Conference Call and Webcast of Full Year 2017 Financial Results on March 19, 2018

07/03/2018 - 14:00

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE ), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today [...]

UroGen to Present at March 2018 Investor Conferences

07/03/2018 - 14:00

RA’ANANA, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ) today announced that management plans to present at two investor conferences in March 2018: Cowen & Company 38 th [...]

Insmed to Present at the Cowen and Company 38th Annual Health Care Conference

07/03/2018 - 14:00

BRIDGEWATER, N.J., March 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that a member of [...]

Catalyst Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference

07/03/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO ), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]